PBSV Stock Pharma-Bio Serv (PBSV, $0.58) was a top weekly gainer, with a +5.07% jump

GET DAILY SIGNALS

Get AI intraday signals

PBSV - Pharma-Bio Serv, Inc.

Loading...

Price: $0.58

Daily change: +$0.0415 (+7.71%)

Daily volume: 1.6K

Weekly price change: +$0.028 (+5.07%)

Capitalization: $13.3M

Industry: Services to the Health Industry

Pharma-Bio Serv (PBSV, $0.58) was one of the top gainers this week, climbing to $0.58 per share. A.I.dvisor analyzed 93 stocks in the Services to the Health Industry Industry over the last week and discovered that of them (6) trended up while of them (3) trended down.

PBSV's Stochastic Oscillator sits in overbought zone for 1 day

Expect a price pull-back in the near future.

Technical Analysis (Indicators)

Bearish Trend Analysis

PBSV broke above its upper Bollinger Band on December 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 22, 2025. You may want to consider a long position or call options on PBSV as a result. In of 148 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PBSV just turned positive on December 10, 2025. Looking at past instances where PBSV's MACD turned positive, the stock continued to rise in of 76 cases over the following month. The odds of a continued upward trend are .

PBSV moved above its 50-day moving average on December 22, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PBSV advanced for three days, in of 70 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 105 cases where PBSV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PBSV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.115) is normal, around the industry mean (21.632). P/E Ratio (20.231) is within average values for comparable stocks, (105.725). PBSV's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.394). Dividend Yield (0.000) settles around the average of (0.028) among similar stocks. P/S Ratio (1.450) is also within normal values, averaging (67.308).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PBSV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.